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ABSTRACT After 24 h of continuous labeling with radioactive precursors, a high molecular
weight heparan sulfate proteoglycan (HS-PG) was isolated from both the medium and cell
layer of human colon carcinoma cells (WiDr) in culture. The medium HS-PG eluted from a
diethylaminoethyl anion exchange column with 0.45-0 .50 M NaCl, had an average density of
1 .46-1 .49 g/ml on dissociative CsCI density-gradient ultracentrifugation, and eluted from
Sepharose CL-2B with a Kav = 0.57. This proteoglycan had an estimated Mr of =8.5 x 105,
with glycosaminoglycan chains of Mr = 3 x 104 which were all susceptible to HN02
deaminative cleavage. Deglycosylation of the HS-PG with polyhydrogen fluoride resulted in a
3 H-core protein with Mr =2.4 x 105. The cell layer contained a population of HS-PG with
characteristics almost identical to that released into the medium but with a larger Mr = 9.5 x
105. Furthermore, an intracellular pool contained smaller heparan sulfate chains (Mr =1 x 104)
which were mostly devoid of protein core. In pulse chase experiments, only the large cell-
associated HS-PG was released (-58%) into the medium as intact proteoglycan and/or
internalized and degraded (-42%), with a t1 /2 = 6 h . However, the small intracellular
component was never released into the medium and was degraded at a much slower rate.
When the cells were subjected to mild proteolytic treatment, only the large cell-associated
HS-PG, but none of the small component, was displaced. Addition of exogenous heparin did
not displace any HS-PG into the medium . Both light and electron microscopic immunocyto-
chemistry revealed that the cell surface reacted with antibody against an HS-PG isolated from
a basement membrane-producing tumor. Electron microscopic histochemistry using ruthe-
nium red and/or cuprolinic blue revealed numerous 10-50-nm diam granules and 70-220-
nm-long electron-dense filaments, respectively, on the surface of the tumor cells. The results
indicate that colon carcinoma cells synthesize HS-PGs with distinct structural and metabolic
characteristics: a large secretory pool with high turnover, which appears to be synthesized as
an integral membrane component and localized primarily at the cell surface, and a small
nonsecretory pool with low turnover localized predominantly within the cell interior. This
culture system offers an opportunity to investigate in detail the mechanisms involved in the
regulation of proteoglycan metabolism, and in the establishment of the neoplastic phenotype.
Proteoglycans are major constituents of the extracellular ma-
trix and cell surface. They are complex macromolecules in
which glycosaminoglycan side chains are covalently linked to
a protein core forming polydisperse populations of proteogly-
can monomers (1). Although significant progress has been
made in elucidating the structure of cartilage proteoglycans
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(1-8), relatively little is known about the noncartilaginous
proteoglycans, but their ubiquitous distribution and strategic
location among tissues suggest that they play important phys-
iological roles (9, 10).
Since the discovery of cell-associated heparan sulfate (11),
it has been evident that this macromolecule is intimately
403involved with fundamental cellular processes such as cell
growth, receptor binding, and transformation (9, 12). The cell
surface heparan sulfate can self-interact via its side chains (13)
and is a critical mediator of cell adhesion by specific interac-
tions with fibronectin (14), laminin (15), and collagen (16).
Recent studies (17) indicate that these macromolecules are
complexed at the cell surface, and that heparan sulfate pro-
teoglycan plays an important role in the assembly of such
supramolecular complexes.
Heparan sulfate has also been shown to be qualitatively
different in transformed cells. In particular, it has been found
that the degree of sulfation is markedly reduced upon trans-
formation with SV40 (18, 19), and that this undersulfation
occurs predominantly in 0-sulfate groups of the heparan
sulfate chains (20). It is noteworthy that in vivo studies of
human hepatomas have also identified a class of heparan
sulfate with a lower degree of sulfation as compared With
normal human liver (21), and this difference is specific for
heparan sulfate (21). These studies have proposed that changes
in heparan sulfate may be related to the altered cell interaction
and growth behavior of transformed cells.
We have previously demonstrated (22) that normal human
colon tissue maintained in organ culture synthesizes two
major classes of proteoglycans: a large monomer containing
heparan sulfate, and a smaller monomer containing dermatan
sulfate. Colon carcinoma tissue, on the other hand, synthe-
sizes predominantly a small chondroitin sulfate-rich proteo-
glycan and lesser amounts of heparan sulfate proteoglycan.
We have also shown, using both cytochemistry and autora-
diography (23), that the mesenchymal cells surrounding the
tumor are active in the synthesis of sulfated proteoglycans.
These previous findings have raised the possibility that the
heparan sulfate proteoglycan is synthesized primarily by the
neoplastic epithelial cells, whereas the small chondroitin sul-
fate proteoglycan is synthesized by the connective tissue
stroma surrounding the invasive tumor cells.
In the present study, we have investigated in detail the
biosynthesis, secretion, and topographical distribution ofpro-
teoglycans in cultured carcinoma cells derived from a spon-
taneous human colon carcinoma. The results demonstrate
that cultured colon carcinoma cells synthesize exclusively
heparan sulfate proteoglycans with distinct location and me-
tabolism: a "secretory" pool, which is located primarily at the
cell surface and is partly released by limited proteolysis and
partly internalized and degraded, and a "nonsecretory" pool,
which is mostly intracellular, never released, and slowly de-
graded.
MATERIALS AND METHODS
Materials:
￿
All the chemicals used were ofanalytical grade unless oth-
erwise stated. Guanidine HCI (grade I), phenylmethylsulfonyl fluoride, and
anisole were purchased from Sigma Chemical Co. (St. Louis, MO); cesium
chloride from Matheson, Coleman and Bell (Elk Grove Village, IL); benzami-
dine HCI, 6-aminohexanoic acid, and ruthenium red from Eastman Kodak
Co. (Rochester, NY); Zwittergent 3-12 was from Calbiochem-BehringCo. (San
Diego,CA); and pyridinium polyhydrogen fluoride from PCR Inc. (Gainesville,
FL); Sepharose CL-2B, CL-6B, Sepharyl-300, Sephadex G-25 (PD-10), and
DEAE-Sephacel from Pharmacia Fine Chemicals (Piscataway, NJ); papain
from Worthington Biochemical Corp. (Freehold, NJ). Dulbecco's modified
Eagle's medium, fetal calf serum, and trypsin were purchased from GIBCO
Laboratories, Grand Island Biological Co. (Grand Island, NY). Carrier-free
35S0`1- as sodium salt (900 MCi/mmol), t.-[G-'H]serine (19 Ci/mmol), í.-
[3,4,5'H (N)]leucine (141 Ci/mmol), and D-[6-'H (N)]glucosamine HCl (19.7
Ci/mmol) were obtained fromAmersham Corp. (Arlington Heights, IL). Chon-
droitinase ABC (Proteus vulgaris), AC II (Arthrobacter aurescens), and glycos-
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aminoglycan standards were from Miles Laboratories Inc. (Elkhart, IN). He-
paritinase from Flavobacteriumheparinum was a generous gift ofDr. A. Linker,
University of Utah (Salt Lake City). Affinity-purified antibodies raised against
the protein core of the heparan sulfate proteoglycan from the Engelbreth-
Holm-Swarm tumor were a generous gift of Dr. J. Hassell, National Institute
of Dental Research, NIH. Proteoglycan monomer (A,-D,)' and aggregates (A,)
from bovine nasal cartilage weregenerousgifts ofDr. L. Rosenberg, Montefiore
Hospital (Bronx, NY). Proteoglycan monomers (D,)' from Swarm rat chondro-
sarcoma were generous gifts of Dr. T. N. Wight, University of Washington
(Seattle). Protein standards for calibration of the columns and for SDS PAGE
were from Bio-Rad (Richmond, CA). The Aquapore columns for the high-
performance liquid chromatography (HPLCY were bought from Brownlee
Laboratory (Santa Clara, CA). Cuprolinic blue was from Gallard Schlesinger
Chemical Mfg. Corp. (Carle Place, NY).
Cell Culture and Metabolic Labeling:
￿
Human colon carcinoma
cells (WiDr) were purchased from the American Type Culture Collection
(Baltimore, MD). By both scanning and transmission electron microscopy,
these cells revealed a rich microvillar surface and well-developed junctional
complexes (not shown), which are characteristically found in neoplastic cells of
epithelial origin. The cells were cultured in 75-cm2 Falcon flasks (Becton,
Dickinson & Co., Sunnyvale, CA) in Dulbecco's modified Eagle's medium
supplemented with 100 U/ml of penicillin, 100 jig/ml ofstreptomycin sulfate,
and 10% fetal calfserum (Gibco Laboratories). After reaching confluency in a
humidified atmosphere of 5% C02 and 95% air at 37°C, the cells were washed
twice with Hanks' balanced salt solution (HBSS) and metabolically labeled in
the presence or absence of serum. Radioactive precursors included 40 ACi/ml
of carrier-free ['SS]sulfate alone or in combination with 10 UCi/ml of L-['H]
serine, t.-['H]leucine, or o-['H]glucosamine. Steady state was reached between
20 and 24 h (see Fig. 1), and the cells were metabolically labeled for at least 24
h in all the experiments described in this paper.
Isolations of Proteoglycans:
￿
After labeling, the incubation me-
dium was removed, the cell layer ("10' cells/flask) was washed twice with
HBSS and the washes were combined with the medium. Solid guanidine HCI
(0.5 g/ml) was added and the solutions were either processed immediately or
frozen at -70°C until subsequent analysis. Proteoglycans in the cell layer were
solubilized at 4°C using the sequential addition of 8% Zwittergent 3-12, 30
min, and 8 M guanidine HCI, 50 mM sodium acetate, pH 6.0, 30 min (24) in
the presence ofthe following protease inhibitors (25): 20 mM sodium EDTA,
5 mM benzamidine HCI, 0.1 M 6-aminohexanoic acid, and 2 mM phenylme-
thylsulfonylfluoride. The combinedextracts ("-8 ml) were removed and the cell
layers were extracted for an additional 30 min with 4% Zwittergent 3-12, and
4 M guanidine HCI (-6 ml). The solutions were centrifuged at 1,500 g to
remove cellular debris, and the unincorporated radioisotopes were removed
from all samples by gel chromatography on prepacked Sephadex G-25 (PD-10)
columns, equilibrated, and eluted with 4 M guanidine HCI, 0.1 M sodium
sulfate, pH 7.0, containing 0.2% Triton X-100.
Purification of Proteoglycans:
￿
The material eluted at the excluded
volumes of PD-10 columns was dialyzed against distilled water at 4°C and
lyophylized. The samples were dissolved in 1-2 ml of50 mM Tris-HCI buffer,
pH 8.0, 0.1 M NaCl in 8 M urea, and 0.2% Triton X-100, and applied to an
8-ml DEAE-Sephacel column equilibrated with the same buffer (Yanagishita,
M., and V. C. Hascall; personal communication). The DEAE column was
washed with -30 ml of equilibration buffer and then eluted with a linear
gradient (30+30 ml) from 0.1 to 0.8 M NaCl, under a constant flow rate of 5
ml/h. Linearity of the gradient was confirmed by measuring the conductivity
ofvarious fractions and converting the obtained values to NaCl concentrations
by use of a standard curve. Fractions eluting at high salt concentration (0.4-
0.5 M) were pooled, concentrated by dialysis and lyophylization, and resus-
pended in 4 M guanidine HCI buffer in the presence of protease inhibitors.
Isopycnic CsCl density-gradient ultracentrifugation(starting p = 1.41 g/ml)was
performed for 48-60 h at 10°C, 37,000 rpm in a Beckman SW-50.1 rotor
(Beckman Instruments, Inc., Fullerton, CA). Gradients were divided into 10
equal fractions (500 kl each) using an Auto Densi-Flow II (BuchlerInstruments
Inc., Ft. Lee, NJ) and the distribution of radioactivity and density in 100-ul
aliquots ofeach fraction was determined. Portionsof the CsCl density-gradient
fractions were applied to an analytical Sepharose CL-2B column (0.6 x 90 cm)
eluted with 4 M guanidine HCI, 50 mM sodium sulfate buffer, pH 7.0, with
0.2% Triton X-100. Fractions of 0.5 ml were mixed with 10 ml of Redi-
SolvTMEP (Beckman Instruments, Inc.) and analyzed for radioactivity in a
' The nomenclature D,-D,o indicates fractions recovered from the
bottom to top of dissociative (4 M guanidine HCI) CsCl density-
gradient ultracentrifugation.
'Abbreviations used in this paper: HBSS, Hanks' balanced salt solu-
tion; HPLC, high-performance liquid chromatography.Beckman LS-6800 scintillation counter (Beckman Instruments, Inc.). Appro-
priate quenching curves for the various bufferswere determined; efficiency was
calculated with H number, and corrections for the shift of"S radioactivity into
3H channel were made.
Proteoglycan-enriched samples were resuspended in 0.1 M Tris-sulfate
buffer, pH 7.0, and subjected to HPLC as previously described (26). This system
utilized two Aquapore columns OH-500 and OH-1000 (4.6 x 250 mm each)
in tandem, with nominal exclusion limits in H2O as determined with dextrans
of 2 and 20 x 106, respectively. Samples of 50-100 pl (1-2 x 10` cpm, '$)
were subjected to HPLC under a constant pressure of --500 psi and a flow rate
of0.5 ml/min. The HPLC columns were calibrated using proteoglycans from
bovine nasal cartilage and rat chondrosarcoma as well as proteins of known M
as described previously (26). The recovery of radiolabeled macromolecules
exceeded 95% .
Characterization of Glycosaminoglycans: Glycosaminogly-
cans were released from proteoglycans by alkaline borohydride treatment (27)
and/or papain digestion (28). The released glycosaminoglycans were chromat-
ographed on an analytical Sepharose CL-6B column eluted with 0.5 M sodium
acetatebuffer, pH 7.0, and their relative average molecularweightwas estimated
as described (29). The "S-labeled glycosaminoglycans were subjected to HN02
degradation (30), and/or chondroitinase ABC and AC-II treatments (31). The
degree of sulfation was determined by electrophoresis in 0.1 N HCI, pH 1 .0,
where only the sulfate groups are ionized (32), and by elution from anion-
exchange chromatography.
Analysis of Core Protein:
￿
Proteoglycanmonomers derived from the
bottom fifth of CsCl density gradients (D,+D2) were deglycosylated with a
modified polyhydrogen fluoride treatment (33). Briefly, 100 pl of anisole
scavenger and l ml of 70% polyhydrogen fluoride in pyridine buffer were
added to a lyophylized aliquot ofpurified proteoglycans doubly labeled with t.-
['H]leucine and ["S]sulfate. The mixture was stirred for 20-30 min and then
dried under vacuum. In preliminary experiments, several incubation times (up
to 8 h) were tested. However, significant degradation of the core peptide was
found if incubation was protracted for more than 30 min. Other procedures to
release the heparan sulfate chains from the core protein, such as heparitinase
treatment, resulted in a marked degradation of the core peptide even when
0. l % bovine serum albumine (wt/vol) was present to minimize proteolysis of
the radiolabeled peptide core.' The dried samples were resuspended in a large
(-20 ml) volume of H2O, dialyzed and lyophylized, and then subjected to
chromatography on Sephacryl S-300 in 0.2 M NaCl, 0.1 M Tris-HCI buffer,
pH 7.0 (33). SDS PAGE before and after deglycosylation was performed
according to Laemmli (34) on 10% polyacrylamide slab gels 1 .5 mm thick.
After electrophoresis the gels were placed in 10% trichloroacetic acid and 20%
methanol at 4°C for 30 min, and were stained with Coomassie Brilliant Blue
R-250 to detect the protein standards or incubated with Enlightening (New
England Nuclear, Boston, MA) for 30 min, washed, and dried under vacuum
at 80°C. The dried gels were then prepared for autoradiography using Kodak
X-OMAT AR film (Eastman Kodak Co.). Amino acids were analyzed as
previously described (25).
Release of Surface Proteoglycans by Trypsin or Heparin:
Confluent monolayers were incubated with radioactive precursors for 24-48 h
in 2 ml of Dulbecco's modified Eagle's medium supplemented with 5% calf
serum. The cells were then washed with 3 x 1 ml of Dulbecco's modified
Eagle's medium and then incubated for 15 min in isotope-free medium in the
presence or absence of 0.1% trypsin (35). This treatment did not cause any
significant cell detachment or damage. Proteolysis was stopped with soybean
trypsin inhibitor, and the medium was removed. The cell layer was washed
with 2 ml of Dulbecco's modified Eagle's medium and the remaining material
was extracted with Zwittergent 3-12 and 4 M guanidine HCI as above. The
material was studied by gel chromatography on Sepharose CL-2B and by
isopycnic CsCl density-gradient ultracentrifugation as above (starting p = 1 .45
g/ml). To determine the relative amounts ofproteoglycans that were bound to
the cell surface through ionic interactions, various concentrations (10-500 ug/
ml) of exogenous heparin were added to confluent monolayers which have
been labeled for 24 h with the same concentrations of isotopes (36). After 30
min of incubation, the amount of labeled proteoglycans in the medium and
cell layer was determined as above.
Pulse Chase Experiments:
￿
To determine the fate of the cell associ-
ated proteoglycans, pulse chase experiments were performed. Confluent mon-
olayers were labeled with t.-['H] leucine (10 pCi/ml) and ["S]sulfate (40 pCi/
ml) for 24 h. The medium was removed and the cell layers were washed three
' Treatment with heparitinase (0.1-1 .0 mg/ml) for 15 min also re-
sulted in severe damage to the cells, as determined by electron
microscopy, indicating that this enzyme preparation was contami-
nated with proteases. This enzyme, therefore, was not further used.
times with HBSS and chased in isotope-free medium for various periods of
time. Macromolecular as well asfree ["S]sulfate radioactivity from the medium
and cell layerat various chase times wasquantitated by PD-10 chromatography.
Sepharose CL-2B chromatography was also performed to determine whether
the macromolelcular radioactivity excluded by PD-10 was present as intact
proteoglycan.
Light and Electron Microscopic Immunocytochemistry:
Colon carcinoma cells were grown to confluency and, after several washes in
HBSS, were fixed for 30 min at 4°Cin either 95% ethanol or Zamboni's fixative
(37). The cells were washed three times in phosphate-buffered saline, incubated
with various dilutions of rabbit anti-heparan sulfate proteoglycan antibodies
(38), and then incubated with fluorescenn isothiocynate-conjugated goat anti-
rabbit antibodies. Slides were examined with a Leitz fluorescent photomicro-
scope (E. Leitz, Inc., Rockleigh, NJ) equipped with epillumination. For im-
munoelectron microscopy, monolayers were fixed in either 1% glutaraldehyde
in phosphate-buffered saline or Zamboni's fixative and were processed as
previously described (39) with minor modifications. After fixation, the cells
were washed several times in phosphate-buffered saline and then treated with
3% H202 in H2O for 30 min to inhibit endogenous peroxidase activity. The
cells were rinsed in phosphate-buffered saline and then sequentially incubated
with normal goat serum (1:5), primary rabbit antibodies (1 :100), goat anti-
rabbit IgG, and then rabbit peroxidase antiperoxidase. The peroxidase reaction
was developed by incubating in diaminobenzidine solution with H202. After
washing in phosphate-buffered saline for 30 min, the cells were photographed,
and then reacted with 1 % OsOy for 30 min, dehydrated in graded ethanols,
and embedded in Epon. Unstained 40-60-nm-thinsections were observed with
a Hitachi-6000 electron microscope, at 50 kV (Hitachi America, Ltd., Allen-
dale, NJ).
Electron Microscopic Cytochemistry of Surface Proteo-
glycans:
￿
Monolayers grown in the absence of serum were fixed in the
presence of ruthenium red (l0, 23), a cationic dye capable of retaining and
binding to proteoglycans (40). Thin sections were sequentially stained with
uranyl acetate and lead citrate (41) and examined by electron microscopy.
Polycarboxylated and polysulfated surface macromolecules were distinguished
by processing monolayers in the presence ofcuprolinic blue in either 0.1 M or
0.3 M MgC12, according to the critical electrolite concentration method (42,
43). As further control, adult rat tail tendons were processed at the same time
in the presence or absence of the dye in 0.1 M and/or 0.3 M MgC12 as above.
Parallel monolayers were incubated with chondroitinase ABC (31) for 30 min
or trypsin (0.1 mg/ml) at 37°C for 15 min before processing in the presence of
the cationic dyes.
Stereologic Analysis of Cuprolinic Blue-stained Proteo-
glycans:
￿
Because the cuprolinic blue-stained filaments are interpreted to
represent extended proteoglycans (42, 43), quantitative studies ofthe length of
the Cuprolinic Blue filaments were performed. Randomly selected pictures
were analyzed quantitatively at a final magnification of 60,000-90,000. Mag-
nification was calibrated with a carbon-grating replica carrying 21,600 lines
cm-' (Ernest F. Fullam, Inc., Schenectady, NY). An appropriate sample size
was determined statistically (44), and section thicknesswas estimated using the
"fold" method (45). Because the cuprolinic blue proteoglycans appeared as
electron-dense linear structures of variable length, random orientation, and
constant thickness (see Results), it was possible to estimatethe true length from
the mean "observed" projected length (46): L = II/2 x L; where L is the true
length ofa straight segment randomly oriented in a volume, and L' is the mean
projected length. This approach is feasible, because in a system of projected
lines in a space or volume, overlap is a highly improbable event (46) if the
section thickness (T) is smaller than the average length (L) and, in particular,
if TIE < 2. In the present study, we found T/L = 0.56 ± 0.06.
RESULTS
Synthesis and Secretion of Proteoglycans
After a lag period of -4 h, the secretion of 'SS-labeled
macromolelcules into the medium increased rapidly and al-
most linearly for up to 68 h (Fig. 1). In the cell layer, the
accumulation of the 35S-labeled material increased rapidly
between 4 and 18 h, and then more slowly, reaching a plateau
after 24 h and staying fairly constant up to 68 h. In most
experiments, cultures were labeled for 24 h at which time the
cells had reached a steady state with -70% of the 35S-macro-
molecule present in the culture medium and -30% in the cell
layer (Fig. 1). The kinetics of accumulation and secretion of
D-['Hlglucosamine-labeled macromolelcules were similar to
lozzo
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405those of the 'SS-labeled macromolecules, although in the
former case, the radioactivity was equally divided between
the medium and cell layer after 24 h incubation (not shown).
In accordance with previous reports (24, 35), sequential ex-
traction with Zwittergent 3-12 and guanidine HCl solubilized
nearly 100% of the labeled macromolelcules from the cell
layer.
Purification of Proteoglycans
The labeled macromolelculesrecovered from both medium
and cell layer were concentrated and subjected to anion-
io
TIME (h)
FIGURE 1
￿
Accumulation of 35S-labeled macromolecules in culture
medium (*) and cell layer (O) of human colon carcinoma cells.
Aliquots (0.5 ml) of medium and Zwittergent-guanidine HCI ex-
tracts of the cell layer were chromatographed separately on PD-10
columnsin the presence of proteoglycan monomer carrier (250 Ag)
from rat chondrosarcoma. Each value represents the average of
triplicate cultures with SD < 10% of the mean.
FIGURE 2 Ion exchange chromatography
on DEAE-Sephacel of ['SS]sulfate- (0) and
['H]leucine-labeled (O) medium (A) andcell
layer (B) from human colon carcinoma cells.
The arrow indicates the starting of the gra-
dient. Polyanionic fractions from medium
(M-111) and cell layer (C-111) were pooled for
further analysis.
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exchange chromatography on DEAE-Sephacel, in the pres-
ence of 8 M urea and 0.2% Triton X-100 and a linear gradient
from 0.1 to 0.8 M NaCl. The polyanionic macromolecules
(peak III, Fig. 2) were clearly separated from the bulk of the
glycoprotein (peaks I and I1), which did not bind to the DEAE.
The majority (-95%) of the "S radioactivity was present as a
sharp peak in both the medium (M-III) and cell layer (C-III)
eluting at the same salt concentration (0.5 M). In the cell
extract, a small shoulder of 'SS-labeled material was also
present in C-III eluting with 0.45 M NaCl (Fig. 2B). Further-
more, the radiolabeled macromolecules in C-III had a much
higher 'H/'SS ratiothan those present in M-III in preparations
labeled with ['SS]sulfate and either L-['H]leucine or L-['H]
serine.
The M-III and C-III fractions were pooled separately, con-
centrated, and further purified by ultracentrifugation in a
CsCI density gradient (Fig. 3). In the medium the majority of
'SS radioactivity (-60%) was recovered in the bottom three
fractions (D,-D3)' with densities higher than 1 .38 g/ml, and
the remainder was distributed in the fractions with interme-
diate and low densities (Fig. 3A). In the cell layer a large
proportion of 'SS radioactivity was also recovered in the
higher-density fractions (Fig. 3B). However, significant
amounts of 'SS activity were found in the fractions of lower
buoyant density, and up to 54% of [3H]leucine radioactivity
sedimented in the top three fractions. To determine the
composition and relative hydrodynamic size ofthe proteogly-
cans from medium and cell layer, we pooled the original
fractions from the CsCI density-gradient ultracentrifugation
to yield five approximately equal fractions. For M-111, the
fractions of highest buoyant density (D, + Dz, 1.46 g/ml)
contained a single population of proteoglycans that eluted
from Sepharose CL-2B with a Kav = 0.57 and ['H]Leu/'SS
ratio of 1 .1 (Fig. 4A). This proteoglycan was distributed
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FIGURE 3 CsCl density-gradient ultracentrifugation of DEAE-Se-
phacel-purified proteoglycans from medium (A) and cell layer (B).
Isopycnic CsCl density-gradient ultracentrifugation (starting p= 1 .41
g/ml) was performed for 48 h at 10°C, 37,000 rpm in a Beckman
SW-50.1 rotor. Fractions of 500 pl were collected and 100-pl
aliquots were analyzed for [35S]- (") and ['H]leucine radioactivity
(0) and for density (- - -).
throughoutall fractions ofthe gradient in decreasing amounts
from bottom to top. The ['H]Leu/"S ratio in this peak
increased from 1 .1 in the fraction of highest density to 2.5 in
the fraction of lowest density (Fig. 4A), suggesting a higher
proportion of glycosaminoglycan to protein in the bottom
fractions. Furthermore, no contaminant 3H-labeled proteins
were found in the proteoglycan-enriched fractions, whereas
significant amounts of 3H-labeled proteins were found in the
fractions of lower density eluting before and after the major
proteoglycan peaks. In the cell layer, however, two distinct
populations of macromolecules were found: a large popula-
tion (peak A, Fig. 4B) which eluted slightly earlier (Ka =
0.55) than the large proteoglycans of the medium, and a
smaller population (peak B, Fig. 4B) which eluted near the
V of the column. The large proteoglycan population was
found in all the fractions of the gradient in decreasing con-
centration from bottom to top, and the [3H]Leu/"S ratio for
this peak increased from 1 .5 in the fraction of highest density
to 21 .3 in the fractions oflowest density (Fig. 4B). The results
indicate that the CsCl density-gradient ultracentrifugation
effectively purified most ofthe proteoglycan from lowerbuoy-
ant-density glycoproteins, and that the larger hydrodynamic
size of the cell-associated proteoglycan may be due in part to
a higher protein content, 3H/35S ratio of 1 .5 vs. 1 . l .
The average molecular size of the proteoglycan monomers
in the bottom fraction was also studied by HPLC (26). The
retention time of the medium proteoglycan, Tr = 10 min (Fig.
5A), differed from that of the cell layer, Tr = 9 min (Fig. 5 B).
As expected, in cell layer, the minor component (peak B of
Fig. 4B) eluted near the V of the HPLC system with a Tr --
14 min (Fig. 5B). It was estimated, based on the elution
position of proteoglycan monomers from bovine nasal carti-
lage, rat chondrosarcoma, and proteins of known Mr (see
legend to Fig. 5), that the medium proteoglycan had an
average Mr = 8.5 x 105 and the large cell-associated proteo-
glycan had an Mr = 9.5 x 105.
Characterization of the Glycosaminoglycans
The "S-labeled glycosaminoglycans derived from the large
proteoglycan population in the medium (Fig. 6A) and cell
layer (peak A, Fig. 6B) were included in the Sepharose CL-
6B column afteralkaline borohydride treatment with a Kav =
0.42 (Mr = 3 x 104), whereas the smaller cell-associated
component (peak B, Fig. 6C) had a Ka, of 0.63 (Mr = 1 x
104). All the 35S-labeled polysaccharides in both medium and
cell layers were susceptible to deaminative cleavage with
HN02 (Fig. 6, o), but were all resistant to chondroitinase
ABC and AC-II. Identical results were obtained with the
fractions of lower density derived from CsCl ultracentrifuga-
tion indicating that human colon carcinoma cells synthesize
and secrete only one species of sulfated glycosaminoglycan,
heparan sulfate. The "S-glycosaminoglycans from both me-
dium and cell layer co-migrated on electrophoresis in 0.1 M
HCl and eluted at the same ionic strength on DEAE-Sephacel
indicating that they had the same degree of sulfation (not
shown). Furthermore, the smaller cell-associated component
eluted as a broad polydisperse peak (Ka,= 0.51) on Sepharose
CL-6B before treatment with papain or alkaline/borohydride
in contrast with the larger proteoglycans which were excluded
(not shown). These results suggest that this material is com-
posed primarily of single heparan sulfate chains of small
molelcular weight.
Analysis of Core Protein
After deglycosylation with polyhydrogen fluoride, -90% of
the 35S radioactivity was removed and the core protein eluted
as a single sharp peak on Sephacryl S-300 in both the medium
(Fig. 7A) and the large cell layer (Fig. 7B) proteoglycan
preparations. The deglycosylated core protein from the cell
layer, however, eluted from Sephacryl S-300 slightly earlier
(Kav = 0.355, Fig. 7A) than the medium form (Kav = 0.387,
Fig. 7B). The deglycosylated protein cores of both cell and
medium preparations migrated as a single band on SDS
PAGE as detected by autoradiography (Fig. 7Q, with an
estimated Mr =2.4 x 105. The fact that the small difference
in elution behavior on Sephacryl S-300 between medium and
cell preparations could not be clearly detected by SDS PAGE
suggests that the difference between the protein core of me-
dium and cell layer is small.
The amino acid analysis of both medium and cell-associ-
ated heparan sulfate proteoglycan derived from the D, + D2
fractions was similar but not identical (Table I). The major
amino acids were glutamic acid, glycine, alanine, aspartic
acid, valine, leucine, and lysine. No detectable cysteine4 or
methionine was found in both proteoglycan preparations and,
in addition, no proline was detected in the medium proteo-
glycan. The medium proteoglycan contained -15% less hy-
drophobic amino acids as compared to the cellular form (319
vs. 374 residues).
Release of Surface Proteoglycans by Trypsin
or Heparin
Colon carcinoma cells were labeled for 48 h with [35S]
sulfate and either L-[3H]leucine or D-[3H]glucosamine and
subjected to mild trypsinization (34). This treatment removed
up to 26% and 17.5% of the "S- and D-[3H]glucosamine-
Lack of detection of this amino acid may be in part artifactual due
to destruction during acid hydrolysis.
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labeled macromolelcules, respectively, but only 8% of L-['H]
leucine-labeled macromolelcules (Table 11). To determine
what proportion of the proteoglycans was bound to the cell
surface through ionic interactions, we added increasing con-
centrations of exogenous heparin (10-500 wg/ml) to confluent
monolayers, which had been incubated for at least 24 h in the
same concentration of isotopes as above. After 30 min, there
was no significant increase in the release oflabeled proteogly-
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Sepharose CL-2B elution profiles of 'H-'SS-labeled macromolecules synthesized by colon carcinoma cells and purified
by anion exchange chromatography and CsCl density-gradient ultracentrifugation. The ['H]leucine/'SS ratio of the major
proteoglycan peaks in medium (A) and cell layer (B) and the average density for combined fractions are shown. (0) "S; (0) ['H]
leucine.
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cans in the presence of heparin when compared to controls
(Table 11).
The 'H/'SS-labeled macromolecules released during 15 min
of chase in the presence or absence of trypsin were further
studied by gel chromatography on Sepharose CL-2B and CsCI
density-gradient ultracentrifugation. The control sample re-
leased into the medium after 15 min of chase eluted as a
single peak from the Sepharose CL-2B column (Fig. 8A) with
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FIGURE 5 HPLC elution profiles of proteoglycan-enriched frac-
tions (D1 + Dz) purified by DEAE-Sephacel and CsCl density-
gradient ultracentrifugation. Aliquots from medium (A) and cell
layer (B) were subjected to HPLC using two Aquapore columns in
tandem, OH-500 and OH-1000. The samples were run under
constant pressure of -500 psi, and a flow rate of 0.5 mllmin.
Fractions of 0.25 ml were analyzed for radioactivity. The Va and V,
were determined by using aggregate proteoglycan (A,) from bovine
nasal cartilage and free "S042-, respectively. The numbers repre-
sent the elution position detected by ultraviolet at 280 nm of (1)
proteoglycan monomer from bovine nasal cartilage, (2) proteogly-
can monomer from rat chondrosarcoma, (3) thyroglobulin, (4) fer-
ritin, and (5) catalase. "S (0); ['H]leucine (O).
identical characteristics (K., = 0.57) to that isolated from the
medium after 24 h of continuous labeling (see Fig. 4A). On
the other hand, the trypsin-released proteoglycan (Fig. 8 C)
was slightly reduced in hydrodynamic size (Ka, = 0.61),
indicating that trypsin treatment had cleaved a portion of the
peptide core. Furthermore, only the large cell-associated pro-
teoglycan, but none of the small component was accessible to
trypsin. In a CsCl density-gradient ultracentrifugation, the
distribution of the spontaneously released proteoglycan (Fig.
8 B) was similar to that of the trypsin-released proteoglycan
(Fig. 8D). These results indicate that the heparan sulfate
proteoglycan exists as a cell-surface macromolecule and that
it is not bound by electrostatic interactions between the gly-
cosaminoglycan side chains and membrane protein(s).
Turnover of Heparan Sulfate Proteoglycan
The fate ofthe cell-associated heparan sulfate proteoglycan
was determined by studying the turnover of the "S-labeled
macromolecules after chase for various periods of time in
isotope-free medium. The total "S-macromolecules in the cell
layer decreased rapidly and then more slowly with a h1z = 6
h (Fig. 9A ). The nonlinearity ofthe disappearance curve, even
when plotted on logarithmic scale (not shown), indicates that
FIGURE 6
￿
Sepharose CL-6B elution profiles of glycosamínoglycans
released by alkaline borohydride treatment from proteoglycans of
medium (A) and cell layer peak A (B) and peak B (C). Radiolabeled
macromolecules isolated from the proteoglycan-enriched fractions
(D, + Dz) were purified by Sepharose CL-2B. The included peaks
were treated with alkaline borohydride and analyzed by Sepharose
CL-6B chromatography before (9) and after HN02 (O) treatment.
Similar elution profiles were found in the samples treated with
papain.
the turnover of the proteoglycans did not follow simple first-
order kinetics, which suggests that the fractions contain two
or more components with different turnover rates (47). In
fact, when the "S-macromolelcules present in the medium
and cell layer were analyzed by Sepharose CL-2B chromatog-
raphy, it was found that after 12 h only 10-20% of the large
heparan sulfate proteoglycan remained associated with the
cell layer and 58% was found intact in the medium (not
shown), and this proportion remained constant for up to 24
h (Fig. 9B). On the contrary, the small cell-associated com-
ponent was never found in the medium and was degraded at
a much slower rate, because after 24 h of chase, -30% of it
was still found in the cell layer, whereas the larger proteogly-
can was completely metabolized. Free [15S]sulfate was con-
stantly released into the medium with a maximum of 52%
after 24 h ofchase (Fig. 9 C). In the cell layer there was -5%
of free "S radioactivity and this did not change with time
(Fig. 9 C).
Taken together these results indicate that (a) the larger
heparan sulfate proteoglycan localized at the cell surface is
the precursor of the medium proteoglycan; (b) this proteogly-
can is in part (58%) released into the medium as intact
proteoglycan and in part (42%) internalized and degraded; (c)
the cell-associated pool of smaller heparan sulfate is never
released into the medium, does not represent a precursor pool
for the large heparan sulfate proteoglycan, and is degraded at
a much slower rate than the large proteoglycan.
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409FIGURE 7 Sephacryl S-300 elution
profiles (A and B) and SIDS PAGE
autoradiographs (C) of polyhydro-
gen-fluoride-treated proteoglycan
monomers isolated from themedium
and cell layer (peak A of Fig . 46) of
colon carcinoma cells . The deglyco-
sylated proteoglycans, double-la-
beled with [35Slsulfate (0) and [
3
H]
leucine (O), were subjected to Se-
phacryl S-300 chromatography in 0.3
M NaCl, 0.1 MTris-HCI, pH 7.0 . SDS
PAGE was performed in slab polya-
crylamide gels containing 0.1% SIDS
with 5% polyacrylamide stacking gel
and a 10% resolving gel . Protein
standards include myosin, phospho-
rylase b, albumin, ovalbumin, and
lactalbumin with M, of 200, 94, 68,
43, and 14 x 103 , respectively . O,
Origin ; DF, dye front .
TABLE I
Amino Acid Analysis of Proteoglycans Synthesized by Human
Colon Carcinoma Cells*
Light and Electron
Microscopic Immunocytochemistry
* Values represent the average of two analyses on two different preparations
of purified proteoglycans (D, + Dz) with variability<10%.
* Values represent amino acid analysis of peak A (see Fig. 4 B, bottom panel) .
s nd, not detected .
Human colon carcinoma cells reacted with affinity-purified
antibodies raised against the protein core of Engelbreth-
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TABLE II
Release of Cell-surface Proteoglycans by Trypsin and Heparin`
Released macromolecular
radioactivity
* Triplicate confluent cultures were incubated for 24 h with radioactive
precursors . The cells were washed three times with HBSS and incubated
for 15 and/or 30 min at 37°C with trypsin or increasing concentrations of
heparin, respectively . The radioactivity in the medium and cell layer was
calculated as described under Materials and Methods . The values are
expressed as percentage of macromolecular radioactivity released from the
cell layer . None of the radioactivity released by heparin is statistically
different from the control values.
Holm-Swarm tumor heparan sulfate proteoglycan. Fluores-
cence was observed in the form ofpunctuate or linear deposits
especially along the cellular contours, whereascontrol sections
incubated with normal rabbit serum remained totally unla-
beled (not shown) . Immunofluorescence deposits were com-
pletely removed by pretreating the cells with trypsin, but no
immunoreactivity could be displaced by chondroitinase ABC
treatment. Light microscopy (inset, Fig . l0A) of tumor cells
reacted with anti-heparan sulfate and labeled with peroxidase
antiperoxidase revealed intense deposits around the tumor
Incu-
bation
time
min
[35
51 -
Sulfate
%
p_[3Fi]_
Gluco-
samine
%
L-[3Hl-
Leucine
%
Control 15 2 .4 0.8 0.4
+ Trypsin (100 Wg/ml) 15 26 .1 17.5 8.3
Control 30 4.7 1 .9 0.7
+ Heparin (10 Ag/ml) 30 5 .8 1 .6 0.7
+ Heparin (100 jig/ml) 30 5 .6 1 .7 0.7
+ Heparin (500 tig/ml) 30 4.5 1 .4 0.6
Amino acid Medium
residues/1,000
Cell layer*
amino acids
Hydroxyproline nd 4 nd
Aspartic acid 90.6 88 .6
Threonine 20.7 38 .4
Serine 59.5 60 .5
Glutamic acid 190.8 135.5
Proiine nd 37 .6
Glycine 135.7 111 .8
Alanine 108.9 103.8
Valine 87.2 82.6
Cysteine' nd nd
Methionine nd nd
Isoleucine 25 .1 36.0
Leucine 87.9 84.0
Tyrosine 12.4 10.7
Phenylalanine 10.0 28.6
Lysine 80.6 89.0
Histidine 18 .4 16.7
Arginine 72.2 76.20
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FIGURE 9 Turnover of 35S-labeled proteoglycan synthesized by
human colon carcinoma cells. The "S-macromolecules (0) as well
as the free [35S]sulfate radioactivity (A,) were monitored in both the
medium and cell layer as described under Materials and Methods.
cells with a distribution similar to that obtained with immu-
nofluorescence. Immunoelectron microscopy (Fig. l0A) of
the same cells revealed electron-dense deposits of antigen-
antibody complexes localized exclusively at the cell surface,
around microvilli, and along the avillous membrane. The
electron-dense products were seen as nearly continuous de-
posits in close apposition to the plasma membrane (Fig. l0A ).
Normal rabbit serum failed to react with any components of
colon carcinoma cells (Fig. 10B). When the cells were per-
meabilized with the freezing-thawing method (48), no signif-
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FIGURE 8 Sepharose CL-2B elution
profiles (A and C) and CsCI density-gra-
dient ultracentrifugation (B and D) of
proteoglycans released from colon car-
cinoma cells with or without mild pro-
teolytic treatment. The cells were incu-
bated with isotopes for 24 h, washed
with HBSS (x3) and then chased for 15
min in isotope-free medium in the ab-
sence or presence of trypsin (0.1 mg/ml,
37°C). The released material was de-
salted through PD-10 columns and sub-
jected to chromatography on Sepharose
CL-2B and isopycnic CsCl density-gra-
dient ultracentrifugation (starting p =
1 .45 g/ml) in the presence of 4 M gua-
nidine HCl and protease inhibitors.
icant immunoreactivity was noted in the cytoplasmic com-
ponents of colon carcinoma cells. The results indicate that
the heparan sulfate proteoglycan synthesized by human colon
carcinoma cells is immunologically related to that synthesized
by Engelbreth-Holm-Swarm tumor and that it is localized
predominantly at the cell surface, in agreement with the
biochemical data.
Electron Microscopic Cytochemistry of
Surface Proteoglycans
Numerous ruthenium red positive granules, 20-50 nm in
diameter, were observed on the outer plasmalemmal surface
of the tumor cells (Fig. 11 A). These granules, which are
thought to represent collapsed proteoglycan monomers (10,
23, 40, 49), were present in both the microvillar surface and
along the avillous portion of the plasma membrane. No
granules were observed in cellsprocessed without the cationic
dye (Fig. 11 B), nor were they seen in cellsthat were subjected
to mild proteolysis. Chondroitinase ABC also did not remove
any significant amount of ruthenium red-positive material.
Polycarboxylated and polysulfated surface glycoconjugates
were distinguished by processing the cells in the presence of
cuprolinic blue using the critical electrolyte concentration
approach (42, 43). With high MgC1 2 concentration (0.3 M),
the uptake of the dye is relatively specific for sulfate-contain-
ing polyanions, whereas polycarboxylated and polyester phos-
phates remain unstained (42, 43). Colon carcinoma cells
contained numerous cuprolinic blue-positive structures on
the cell surface (Fig. 12). No difference was notedwhether the
cells were incubated with the dye in the presence of 0.1 M
(Fig. 12A) or 0.3 M MgCl2 (Fig. 12B), indicating that these
cuprolinic blue filaments were polysulfated. These structures
were filamentous and unbranched and often projected from
the surface ofthe microvillias well as from the avillous portion
of the plasma membrane. Occasionally, cuprolinic blue fila-
ments were seen intracellularly and were exclusively localized
in the cistemae ofGolgicomplexes. After mild trypsinization,
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Electron microscopic immunocytochemistry of human carcinoma cells reacted with anti-heparan sulfate antibodies
(A) and normal rabbit serum (B) . The inset represents a light micrograph of same cells with strong surface positivity before reaction
with 0504 and further processing for immunoelectron microscopy . The peroxidase reaction is localized exclusively at the cell
surface (A) where large amounts of electron-dense material are in close apposition to the plasma membrane . No reaction is seen
over the cytoplasm (Cy) or in the control (B) . (Vi) microvilli . (A) x 96,000. (B) x 75,000 . (Inset) x 120 .
the majority of the cuprolinic blue material was removed
from the cell surface, and only a few, short dotlike structures
remained (not shown) . However, these structures were unaf-
fected by treatment with chondroitinase ABC . The dimension
of these cuprolinic blue filaments varied widely from 20 to
220 nm, and quantitative studies revealed that the mean
corrected length (L) was 124± 6nm (n= 574) . Ultrastructural
examination of rat tail tendon stained in parallel as a control
revealed electron-dense filaments interacting with collagen
with characteristics and measurements (L = 74 ± 8 nm)
identical to those described by Scott (42, 43) .
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These results indicate that colon carcinoma cells express a
surface heparan sulfate proteoglycan which appears as a col-
lapsed granule or as an extended electron-dense linear struc-
ture when ruthenium red or cuprolinic blue is used, respec-
tively .
DISCUSSION
The present study demonstrates that cultured human colon
carcinoma cells synthesize unique species of heparan sulfate
proteoglycans with distinct structural characteristics and met-FIGURE 11
￿
Transmission electron micrographs of ruthenium red-stained colon carcinoma cells . Notice the presence of several
ruthenium red positive granules (PG) on the outer plasma membrane of the tumor cells (A), whereas control tissue processed in
the absence of dye (8) shows no electron-dense granules. (Nu) Nucleus. (Cy) Cytoplasm . (Vi) Microvilli . (A) x 68,000 . (B) x
32,000 .
abolic fates . A large cell-associated proteoglycan with an esti-
mated overall.M, =9.5 x 10 5 , a protein core withM r =2.4 x
10',andheparan sulfate side chains withM, =3 x 104 , appears
to be localized primarily at the surface plasma membrane . A
slightly smaller (Mr - 8.5 x 105) proteoglycan with identical
heparan sulfate side chains is released continuously into the
culture medium . These proteoglycans, therefore, could con-
tain as many as 20 heparan sulfate chains per core peptide,'
and share significant structural similarities with those synthe-
' Preliminary studies have demonstrated that the heparan sulfate
proteoglycan contains a small fraction of O-linked oligosaccharide .
(lozzo, R. V., M. Yanagishita, and V. C. Hascall; manuscript in
preparation .)
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￿
Transmission electron micrographs of cuprolinic blue-stained colon carcinoma cells in the presence of 0 .1 M (A) and
0 .3 M (B) M9Cl z . Notice the presence of numerous electron-dense filamentous structures (PG) on the surface of microvilli (Vi) in
close association with the plasma membrane . The inset in B shows at a higher magnification the linear nature of the cuprolinic
blue-positive structures, which can be >200 nm in length . (Cy) Cytoplasm . (A) x 73,000 . (B) x 72,000 . (Inset) x 105,000 .
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have previously reported (22). The latter proteoglycans differ
from the colon carcinoma proteoglycans described here in
that they have larger hydrodynamic size, higher buoyant
density, but shorter glycosaminoglycan side chains (22). How-
ever, the amino acid composition of their respective protein
cores is similar, particularly in their high content of aspartic
acid, glutamic acid, alanine, and glycine suggesting that they
may be genetically related. Comparison with other heparan
sulfate proteoglycans indicates that the proteoglycan synthe-
sized by colon carcinoma cells is considerably larger than that
of liver plasma membrane (50), fibroblasts (51), or parietal
yolk sac-2 cells (52), but is similar in overall size to that
synthesized by vascular endothelial cells (53) and Engelbreth-
Holm-Swarm tumor (38).
In addition to these two high-M, proteoglycans, the colon
carcinoma cellscontain a cell-associated pool ofsmall heparan
sulfate chains (M, = 1 x 10°). These components are admixed
with small oligopeptides, are neverfound in the medium, and
are not trypsin accessible suggesting that they may be located
in an intracellular compartment. At leastin part, this material
could represent degraded products from the large cell-associ-
ated proteoglycan, with intermediate sized species composed
of truncated proteoglycans. Intracellular pools of heparan
sulfate of small size have been previously described in a variety
of cells (35, 53-55), including embryonal carcinoma (56) and
ovarian granulosa cells (57).
There is also evidence indicating that the large cellular
proteoglycan is a precursor for the medium proteoglycan. In
chase experiments, only the larger heparan sulfate proteogly-
can is released into the medium as intact macromolecule, is
accessible to trypsin, and exhibits nearly identical structural
properties to that released during continuouslabeling. Several
lines of evidence presented here indicate that the release of
the surface heparan sulfate proteoglycan occurs via a "clipping
off" mechanism of its protein core. First of all, the medium
proteoglycan has a smaller hydrodynamic size than the cell-
associated form. Secondly, the deglycosylated protein core of
the medium proteoglycan is slightly smaller, and thirdly, it
contains - 15% less hydrophobic amino acids and a [3H]Leu/
"S ratio significantly lower than the cellular form. The latter
must therefore be either rich in protein or have heparan sulfate
side chains that are sparsely sulfated (51). However, the 35S-
labeled glycosaminoglycans from the medium and cell layer
co-migrate in 0.1 N HCl electrophoresis and elute from
DEAE-Sephacel at the same NaCl molarity, indicating that
they are equally sulfated. Taken together, these results suggest
that the heparan sulfate proteoglycan may follow a biosyn-
thetic pathway similar to that ofintegral membrane glycopro-
teins, in which the core protein could be inserted into the
membrane bilayer or bound to a membrane receptor (58).
After its arrival at the plasma membrane, it may then be
released by limited cleavage of the core protein. Support for
this model derives from recent studies showing that heparan
sulfate proteoglycans from a variety of sources contain lipo-
philic domains and can be solubilized by detergents (59-62).
Furthermore, in the present study, no heparan sulfate could
be displaced by addition ofexogenous heparin, thus indicating
that none of the proteoglycan is bound through ionic inter-
actions ofits side chains with plasma membrane components
(36). However, lack of heparin-mediated displacement does
not exclude the possibility that electrostatic interactions in-
volving the core protein could be responsible for anchoring
the proteoglycan at the plasma membrane.
Previous studies using skin fibroblasts (55) have demon-
strated that, during chase experiments, nearly all the cell-
associated dermatan sulfate is not secreted as macromolecule
but is completely degraded to dialyzable fragments, oligosac-
charides, and/or inorganic sulfate. In the present study, we
have found that after a 24-h chase, a large proportion of the
cell-associated heparan sulfate is secreted into the medium as
intact proteoglycan, whereas the rest is degraded after inter-
nalization. This discrepancy may be due to (a) a difference in
cell types; (b) the fact that fibroblasts do not express a large
amount of cell surface heparan sulfate; and/or (c) that the
metabolism of heparan sulfate differs from that of other
secretory products such as dermatan sulfate-rich proteogly-
cans. In agreement with recent investigations (63), the colon
carcinoma cells metabolize membrane heparan sulfate pro-
teoglycan through intracellular transport and catabolic path-
ways as well as by release into the medium. It has been
speculated that the shedding of heparan sulfate is an event
correlated to cell division and turnover rather than to secre-
tion (64).
The immunocytochemical studies have revealed heavy de-
posits along the surface of colon carcinoma cellsafterreaction
with an antiserum specific for the heparan sulfate proteogly-
can core protein (38). These results have been confirmed at
the ultrastructural level demonstrating coarse electron-dense
deposits on the surface of microvilli and the free plasma
membrane. Ruthenium red staining has revealed numerous
20-50-nm diameter electron-dense granules on the surface of
the tumor cells. These granules are similar to those found in
cartilage and in other soft tissues (10, 23, 40) and are thought
to represent collapsed proteoglycan monomers (49). It has
been shown that when cultured cells are stained with ruthe-
nium red in the presence of serum, they exhibit a thick fuzzy
coat on the surface membrane, whereas the lack of serum
nearly eliminates it (65, 66). In the present study we have
used serum-free medium to culture the tumor cells, and a
rich, fuzzy coat has not been found, indicating that the
electron-dense granules observed on the surface of colon
carcinoma cells are not artifactual but represent polyanionic
macromolecules newly synthesized by the cells. This has been
confirmed by cuprolinic blue staining using the critical elec-
trolite concentration method (42, 43). This approach has a
major advantage over ruthenium red stainingbecauseit allows
visualization of proteoglycan monomers in an extended con-
figuration. Similar extended structures have been recently
demonstrated in arterial smooth muscle cells using Safranin
O (67). The evidence indicating that the cuprolinic blue-
stained filaments are indeed heparan sulfate proteoglycans is
basedupon the following observations; (a) identical structures
are seen in either 0.1 or 0.3 M MgC12 indicating that the
molecules contain polyester sulfate groups; (b) nearly 100%
of the cell surface 'SS-labeled macromolecules are present as
heparan sulfate proteoglycan; (c) the cuprolinic blue material
is sensitive to mild trypsinization, which also removes the
majority of the cell-surface heparan sulfate, but is insensitive
to chondroitinase ABC; (d) electron-dense filaments with
similar characteristics are observed in the rat tail tendon
processed at the same time, with results identical to those of
Scott et al. (42, 43); (e) staining of hyaluronic acid and
glycoprotein could be excluded in that the MgC12 concentra-
tions used in these experiments prevent their staining (42,
43). Thus,the data indicate that these electron-dense filaments
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mers and their length may reflect the length of the core
protein. We have found cuprolinic blue filaments that mea-
sure up to 220 nm in length, surprisingly close to those
obtained with purified cartilage proteoglycans spread and
rotary shadowed with platinum (49). Indeed, the protein core
of this proteoheparan sulfate (Mr. = 2.4 x 105) is similar in
overall size to that synthesized by cartilage cells (1).
In conclusion, this study has demonstrated that human
colon carcinomacellsproduceunique heparan sulfate proteo-
glycans, with distinct structural and metabolic characteristics.
The strategic localization at the cell surface together with the
large hydrodynamic size and charge suggest that these mac-
romolecules may contribute to the altered surface properties
of neoplastic cells. The availability of a well-controlled and
characterized cell culture system and the expression of aber-
rantly high amounts of a single gene product, such as the
heparan sulfate proteoglycan described here, provides an op-
portunity to investigate in detail themechanisms that regulate
proteoglycan metabolism and that concur with the establish-
ment of the neoplastic phenotype.
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